Literature DB >> 29394465

National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival.

David M Guttmann1, Julie Kobie2, Surbhi Grover1, Alexander Lin1, John N Lukens1, Nandita Mitra2, Karin V Rhodes3,4, Weiwei Feng2, Samuel Swisher-McClure1.   

Abstract

BACKGROUND: The purpose of this study was to determine national disparities in head and neck cancer treatment package time (the time interval from surgery through the completion of radiation) and the associated impact on survival.
METHODS: We conducted an observational cohort study using the National Cancer Database of 15 234 patients with resected head and neck cancer who underwent adjuvant radiotherapy from 2004-2012. Predictors of prolonged package time were identified by multivariable linear regression. Survival outcomes were assessed using a multivariable Cox model.
RESULTS: Mean package time was 100 days (SD 23). Package time was 7.52 days (95% confidence interval [CI] 6.23-8.81; P < .001) longer with Medicaid versus commercial insurance. Low income and African American race also predicted for longer package times. All-cause mortality increased an average of 4% with each 1 week increase in treatment package time (hazard ratio [HR] 1.04; 95% CI 1.03-1.05; P < .001).
CONCLUSION: Significant national socioeconomic disparities exist in treatment package time. Treatment delays in this setting may contribute to worse survival outcomes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  disparities; head and neck cancer; head and neck neoplasms; package time; radiotherapy; surgery

Mesh:

Year:  2018        PMID: 29394465     DOI: 10.1002/hed.25091

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

1.  Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.

Authors:  Melissa A L Vyfhuis; Ikumi Suzuki; Soren M Bentzen; Kevin J Cullen; Olga G Goloubeva
Journal:  Oncologist       Date:  2021-04-15

2.  ASO Author Reflections: Head and Neck Cancer Surgery-How Long Can it Wait?

Authors:  Chandler J Rygalski; Songzhu Zhao; Antoine Eskander; Sidharth V Puram; Stephen Y Kang
Journal:  Ann Surg Oncol       Date:  2020-11-13       Impact factor: 5.344

3.  Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.

Authors:  Johannes J Fagan; Vanita Noronha; Evan Michael Graboyes
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

4.  Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma.

Authors:  Tyler A Janz; Joanne Kim; Elizabeth G Hill; Katherine Sterba; Graham Warren; Anand K Sharma; Terry A Day; Chanita Hughes-Halbert; Evan M Graboyes
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

5.  Patterns of care and survival impact of adjuvant chemoradiotherapy for oropharyngeal cancer with intermediate-risk features.

Authors:  Alexander N Goel; Sophia Sangar; Laith Mukdad; Chase M Heaton; William R Ryan; Marilene B Wang; Jennifer L Long; Maie A St John
Journal:  Head Neck       Date:  2019-05-20       Impact factor: 3.147

6.  An assessment of racial differences in epidemiological, clinical and psychosocial factors among head and neck cancer patients at the time of surgery.

Authors:  Anvesh Kompelli; Kathleen B Cartmell; Katherine R Sterba; Anthony J Alberg; Christopher C Xiao; Amit J Sood; Elizabeth Garrett-Mayer; Shai J White-Gilbertson; Steven A Rosenzweig; Terry A Day
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-03-05

7.  The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model.

Authors:  Leandro L Matos; Carlos Henrique Q Forster; Gustavo N Marta; Gilberto Castro Junior; John A Ridge; Daisy Hirata; Adalberto Miranda-Filho; Ali Hosny; Alvaro Sanabria; Vincent Gregoire; Snehal G Patel; Johannes J Fagan; Anil K D'Cruz; Lisa Licitra; Hisham Mehanna; Sheng-Po Hao; Amanda Psyrri; Sandro Porceddu; Thomas J Galloway; Wojciech Golusinski; Nancy Y Lee; Elcio H Shiguemori; José Elias Matieli; Ana Paula A C Shiguemori; Letícia R Diamantino; Luiz Felipe Schiaveto; Lysia Leão; Ana F Castro; André Lopes Carvalho; Luiz Paulo Kowalski
Journal:  Cancer Causes Control       Date:  2021-03-11       Impact factor: 2.506

8.  The impact of COVID-19 on head and neck cancer diagnosis and disease extent.

Authors:  Kimberley L Kiong; Edward M Diaz; Neil D Gross; Eduardo M Diaz; Ehab Y Hanna
Journal:  Head Neck       Date:  2021-03-02       Impact factor: 3.821

9.  COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.

Authors:  Evan Graboyes; John Cramer; Karthik Balakrishnan; David M Cognetti; Daniel López-Cevallos; John R de Almeida; Uchechukwu C Megwalu; Charles E Moore; Cherie-Ann Nathan; Matthew E Spector; Carol M Lewis; Michael J Brenner
Journal:  Head Neck       Date:  2020-06-20       Impact factor: 3.821

10.  Association between treatment package time and clinical predictors in oropharyngeal cancer.

Authors:  Hidenori Suzuki; Tsuneo Tamaki; Hidenori Tsuzuki; Masami Nishio; Daisuke Nishikawa; Shintaro Beppu; Nobuhiro Hanai
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.